Funding
← Back to your selection

GL Ventures

Activity from announced rounds

Activity in this selectionOct 23, 2026 · Asia · Jul 26, 2026

GL Ventures is the Hillhouse-origin early-stage venture firm identified in LTZ and Clipto issuer announcements.

Recorded funding activity

LTZ develops cancer immunotherapies targeting myeloid biology. Clipto supplies tools for searching video and audio libraries, while Anew combines AI models and experiments for drug discovery. These histories remain distinct from the Hillhouse parent and named funds.

Sources
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$290M
1 disclosed · full round size, not this investor’s share

By stage

Seed1
Undisclosed1

By primary sector

Biotech1
Robotics1

By country

China2

Rounds

2 in this selection
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Lead
LatentVerse

LatentVerse develops foundation models that combine perception, prediction and robot action.

Participant